Efficacy of a New Protocol of Premixed 70/30 Human Insulin in Haitian Youth with Diabetes

被引:2
|
作者
Jean-Baptiste, Eddy [1 ]
Larco, Philippe [1 ]
von Oettingen, Julia [2 ,3 ]
Ogle, Graham David [4 ]
Moise, Keddy [1 ]
Fleury-Milfort, Evelyne [1 ]
Paul, Rodolphe [1 ]
Charles, Rene [1 ]
Larco, Nancy Charles [1 ]
机构
[1] Haitian Fdn Diabet & Cardiovasc Dis FHADIMAC, 208 Lalue, HT-6114 Port Au Prince, Haiti
[2] McGill Univ Hlth Ctr, Res Inst, 1650 Cedar Ave, Montreal, PQ H3G 1A3, Canada
[3] Montreal Childrens Hosp, 1001 Blvd Decarie, Montreal, PQ H4A 3J1, Canada
[4] Diabet NSW, Life Child Program, 26 Arundel St, Glebe, NSW 2037, Australia
关键词
Insulin-treated diabetes; Low-resource setting; Missed self-monitoring of blood glucose tests; Premixed insulin; Self-management education; Self-mixed insulin; Skipped meals; Sliding scales; Youth-onset diabetes; DISPARITIES; MANAGEMENT; CHILDREN;
D O I
10.1007/s13300-021-01130-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Controlling insulin-treated diabetes is challenging in low-resource settings where only Neutral Protamine Hagedorn (NPH), regular (R) and premixed insulin formulations are available, self-monitoring of blood glucose (SMBG) supplies are scarce and food insecurity is common. We examined the impact of a treatment protocol that includes sliding scale-based 70/30 insulin adjustments in Haiti. Methods Thirty young patients aged 11-28 years with diabetes treated with premixed 70/30 insulin twice daily were included in the study. The participants performed one or two daily self-monitoring of blood glucose (SMBG) tests and attended our diabetes clinic monthly. They were randomized to two treatment groups, with one group remaining on the 70/30 insulin formulation (group 70 [G70]) and the other group switching to self-mixed NPH + R (group NR [GNR]). Sliding scales for insulin correction doses and meal insulin doses were designed based on the total daily insulin dose (TDD), carbohydrate ratio and insulin sensitivity factor. SMBG tests and insulin were administered before the morning and evening meals. The frequency of visits to the diabetes clinic was increased to biweekly during a 14-week follow-up. Results Fifteen patients of each group were included in the analysis. Baseline characteristics, increase in total daily dose and number of missed SMBG tests and skipped meals at 14 weeks did not differ between the two groups. Hemoglobin A1c (HbA1c) decreased from 9.5% (interquartile range [IQR] 8.8, 10.5) (80.3 mmol/mol) to 8.0% (IQR 7.1%, 9.0%) (63.9 mmol/mol) in G70 (p = 0.01), and from 10.6% (IQR 8.1,% 13.1)% (92.4 mmol/mol) to 9.0% (IQR 7.6%, 9.6%) (74.9 mmol/mol) in GNR (p = 0.10), with no significant between-group difference in reductions (p = 0.12). No serious acute complications were reported. Stopping the use of sliding scales and resuming monthly visits increased HbA1c to values not significantly different from baseline in both groups after 15 weeks. Conclusion The use of sliding scales adjusted for missed SMBG tests and skipped meals, and frequent clinic visits that focus on patient self-management education significantly improved glycemic control in the patients with youth-onset diabetes in our study treated with premixed 70/30 human insulin in a low-resource setting.
引用
收藏
页码:2545 / 2556
页数:12
相关论文
共 50 条
  • [1] Efficacy of a New Protocol of Premixed 70/30 Human Insulin in Haitian Youth with Diabetes
    Eddy Jean-Baptiste
    Philippe Larco
    Julia von Oettingen
    Graham David Ogle
    Keddy Moïse
    Evelyne Fleury-Milfort
    Rodolphe Paul
    René Charles
    Nancy Charles Larco
    [J]. Diabetes Therapy, 2021, 12 : 2545 - 2556
  • [2] Premixed 70/30 insulin aspart suspension improves insulin therapy related QOL in comparison with premixed 70/30 human insulin
    Yamada, S
    Tamada, T
    Suzuki, R
    Yajima, K
    Motohashi, Y
    Shimada, A
    [J]. DIABETES, 2005, 54 : A119 - A119
  • [3] A COMPARISON OF PREMIXED INSULIN PREPARATIONS IN ELDERLY PATIENTS - EFFICACY OF 70/30 AND 50/50 HUMAN INSULIN MIXTURES
    BRODOWS, R
    CHESSOR, R
    [J]. DIABETES CARE, 1995, 18 (06) : 855 - 857
  • [4] Improvement of postprandial hyperglycemia and arterial stiffness upon switching from premixed human insulin 30/70 to biphasic insulin aspart 30/70
    Ohira, Masahiro
    Endo, Kei
    Oyama, Tomokazu
    Yamaguchi, Takashi
    Ban, Noriko
    Kawana, Hidetoshi
    Nagayama, Daiji
    Nagumo, Ayako
    Saiki, Atsuhito
    Murano, Takeyoshi
    Watanabe, Hitoshi
    Miyashita, Yoh
    Shirai, Kohji
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2011, 60 (01): : 78 - 85
  • [5] A direct efficacy and safety comparison of insulin aspart, human soluble insulin, and human premix insulin (70/30) in patients with type 2 diabetes
    Bretzel, RG
    Medding, J
    Arnolds, S
    Linn, T
    [J]. DIABETES CARE, 2004, 27 (05) : 1023 - 1027
  • [6] Insulin aspart efficacy and safety compared to human soluble insulin and human premix insulin (30/70) in patients with type 2 diabetes mellitus
    Bretzel, RG
    Medding, J
    Hirschberger, S
    Linn, T
    [J]. DIABETOLOGIA, 2001, 44 : A209 - A209
  • [7] Premixed insulin aspart 30 (BIAsp 30) versus premixed human insulin 30 (BHI 30) in gestational diabetes mellitus: a randomized open-label controlled study
    Balaji, Vijayam
    Balaji, Madhuri S.
    Alexander, Cynthia
    Srinivasan, Ashalata
    Suganthi, Sheela R.
    Thiyagarajah, Arthi
    Seshiah, Veerasamy
    [J]. GYNECOLOGICAL ENDOCRINOLOGY, 2012, 28 (07) : 529 - 532
  • [8] Premixed insulin aspart 30 vs. premixed human insulin 30/70 twice daily: a randomized trial in Type 1 and Type 2 diabetic patients
    Boehm, BO
    Home, PD
    Behrendt, C
    Kampt, NM
    Lindholm, A
    [J]. DIABETIC MEDICINE, 2002, 19 (05) : 393 - 399
  • [9] Comparison of Premixed Human Insulin 30/70 to Biphasic Aspart 30 in Well-Controlled Patients with Type 2 Diabetes Using Continuous Glucose Monitoring
    Margaritidis, Charalampos
    Karlafti, Eleni
    Kotzakioulafi, Evangelia
    Kantartzis, Konstantinos
    Tziomalos, Konstantinos
    Kaiafa, Georgia
    Savopoulos, Christos
    Didangelos, Triantafyllos
    [J]. JOURNAL OF CLINICAL MEDICINE, 2021, 10 (09)
  • [10] EFFICACY OF A PREMIXED SEMISYNTHETIC HUMAN INSULIN REGIMEN
    BELL, DSH
    CUTTER, GR
    LAURITANO, AA
    [J]. CLINICAL THERAPEUTICS, 1989, 11 (06) : 795 - 801